What is Regulatory Affairs Academy?
11 stand-alone courses altogether covering the regulatory role and requirements in the different phases of drug development, before and after product approval. The course set-up enables you to combine your studies with work or other occupation during one year, starting this October.
And for whom?
For you who aim to work within regulatory affairs for the pharmaceutical industry in Sweden. You may already have started your regulatory affairs career and need to further build and update your knowledge and skills, or you may work within another part of the life science sector right now but have your sights set on a position within the regulatory affairs area. |
|
AstraZeneca
Anne Litzén Forsman, Executive Director Regulatory Affairs Management
“This is a very important educational initiative for AstraZeneca. We are constantly seeking academic talent with regulatory affairs experience for different areas of our business in Gothenburg, Södertälje, and Stockholm. This type of education, although available in many other countries, does not currently exist in Sweden.”
|
|
Naturvetarna
Marita Teräs, Assessor
”As a union, we have initiated this training to strengthen our members’ career opportunities. Life science is the dominant sector for our members and we want to make it possible for more people to equip themselves with the required skills.”
|
|
Aptio Group
Sandra Larsson, Vice VD
”We wish to contribute with our expertise and experience to strengthen the industry with more employees who can work and assist in Regulatory Affairs”
|
|
Science Skills/MultiHelix
Ursula Hultkvist Bengtsson, Chairman of the board/CEO
”Life science in Sweden needs both an addition of regulatory personnel (e.g. newly graduated students and researchers) as well as up-skilling and re-skilling of already working people in Regulatory Affairs or related areas. Several companies act globally, and the availability of expertise is often a decisive factor of where a business should be located. The availability of expertise is central to Sweden’s life science strategy, which states that Sweden should be a leading life science nation. In the current situation, companies are competing for skills and the shortage risks hampering development in the pharmaceutical field and thus delaying patients’ access to medicines.”
|
|
 |
Let us know your needs, ideas and challenges for courses and education! Contact us! |
|
|
Läkemedelsakademin / Swedish Academy of Pharmaceutical Sciences
Wallingatan 26A, Stockholm |
|
|
|
